77,242 Shares in VanEck Biotech ETF $BBH Bought by Quantitative Investment Management LLC

Quantitative Investment Management LLC acquired a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 77,242 shares of the company’s stock, valued at approximately $7,589,000. VanEck Biotech ETF comprises about 0.8% of Quantitative Investment Management LLC’s portfolio, making the stock its 26th largest holding.

A number of other large investors have also recently made changes to their positions in BBH. Kestra Advisory Services LLC increased its position in shares of VanEck Biotech ETF by 3.0% during the first quarter. Kestra Advisory Services LLC now owns 3,405 shares of the company’s stock valued at $640,000 after buying an additional 98 shares during the period. Janney Montgomery Scott LLC grew its holdings in shares of VanEck Biotech ETF by 3.4% during the 1st quarter. Janney Montgomery Scott LLC now owns 3,040 shares of the company’s stock worth $572,000 after acquiring an additional 100 shares during the period. Wealthfront Advisers LLC grew its holdings in shares of VanEck Biotech ETF by 2.3% during the 4th quarter. Wealthfront Advisers LLC now owns 5,513 shares of the company’s stock worth $1,043,000 after acquiring an additional 122 shares during the period. Evelyn Partners Asset Management Ltd grew its holdings in shares of VanEck Biotech ETF by 16.9% during the 4th quarter. Evelyn Partners Asset Management Ltd now owns 941 shares of the company’s stock worth $178,000 after acquiring an additional 136 shares during the period. Finally, Empowered Funds LLC bought a new position in shares of VanEck Biotech ETF in the 4th quarter worth approximately $38,000. 32.05% of the stock is currently owned by institutional investors.

VanEck Biotech ETF Stock Performance

BBH opened at $236.48 on Monday. The business has a 50 day moving average of $212.95 and a 200-day moving average of $197.11. VanEck Biotech ETF has a 52 week low of $160.91 and a 52 week high of $244.35.

Insider Transactions at VanEck Biotech ETF

In other VanEck Biotech ETF news, major shareholder Sardar Biglari sold 6,533 shares of the stock in a transaction on Wednesday, July 15th. The stock was sold at an average price of $16.71, for a total value of $109,166.43. Following the completion of the transaction, the insider owned 3,552,710 shares in the company, valued at approximately $59,365,784.10. This represents a 0.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 10,493 shares of company stock valued at $175,335 in the last ninety days.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.